Skip to main content

The Implementation Strategy for BNCT Trials in Australia

  • Chapter

Abstract

The Australian research program in Neutron Capture Therapy (NCT) had its beginnings in 19821,2 following a visit by the author to Professor Hatanaka in Japan. While the commitment by Ansto has been restrained and relatively constant in recent years at 2-3 person years pa, that of university and medical collaborators continues to grow. This growth in Australian interest has been mirrored by that in the USA, Europe and Japan, and symposia and workshops are now common on the international scene.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen, B.J. Boron neutron capture therapy-a research program for glioblastoma and melanoma. Aust. Phys. Eng. Sci. Med. 6, 184–186 (1983).

    Google Scholar 

  2. Allen, B.J. In vitro and in vivo studies in boron neutron capture therapy of malignant melanoma. Proc. First Int. Symp. Neutron Capture Therapy, MIT, Boston, Oct. 1983. Fairchild, R.G.; Brownell G.L., eds., BNL51730, 341–354.

    Google Scholar 

  3. Tamat, S.R.; Moore, D.E.; Patwardhan, A.; Hersey, P. Boronated monoclonal antibody 225.28S for potential use in neutron capture therapy of malignant melanoma. Pigm. Cell Res. 2, 278–280 (1989).

    Article  CAS  Google Scholar 

  4. Wilson, J.G. Synthetic approach to a decarboranyl thiouracil. Pigm. Cell Res. 2, 297–303 (1989).

    Article  CAS  Google Scholar 

  5. Wilson, J.G. Carborane compounds for neutron capture therapy ofmalignant melanoma. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 227–230 (1992).

    Chapter  Google Scholar 

  6. Moore, D.E.; Chandler, A.K.; Corderoy-Buck, S.; Wilson, G.J.; Allen, B.J. Liposomes as carriers of boronated thiouracils for N CT of melanomas. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 451–454 (1992).

    Chapter  Google Scholar 

  7. Martin, R.F.; Haigh, A.; Monger., C.; Pardee, M.; Whittaker, A.; Kelly, D.P.; Allen, B.J. 157Gd neutron capture: Potential of 157Gd-labelled DNA ligands for neutron capture therapy. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 357–360 (1992).

    Chapter  Google Scholar 

  8. Brown, J.K.; Mountford, M.H.; Allen, B.J.; Mishima, Y.; Thihashi, M.; Parsons, P. Neutron irradiation of human melanoma cells. Pigm. Cell Res. 2, 319–324 (1989).

    Article  CAS  Google Scholar 

  9. Brown, J.K.; Allen, B.J.; Chapman, J.E.; Mountford, M.H.; Parsons, P. In vitro incorporation of BPA by amelanotic and melanotic murine malignant melanoma cells. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 369–372 (1992).

    Chapter  Google Scholar 

  10. Ichihashi, M.; Fukuda, H.; Brown, J.K.; Mountford, M.H.; Allen, B.J.; Mishima, Y. In vitro evaluation of BPA for melanoma at Moata in joint work between Japan and Australia BNCT research teams. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 387–390 (1992).

    Chapter  Google Scholar 

  11. Allen, B.J.; Corderoy-Buck, S.; Moore, D.E.; Mishima, Y.; Ichihashi, M. Local control of murine melanoma xenografts in nude mice by neutron capture therapy. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 425–428 (1992).

    Chapter  Google Scholar 

  12. Corderoy-Buck, S.; Allen, B.J.; Wilson, J.G.; Brown, J.K.; Mountford, M.; Tjarks, W.; Gabel, D.; Barkla, D.; Chandler, A.; Moore, D.E.; Patwardhan, A. Investigation of boron conjugated thiouracil derivatives for neutron capture therapy of melanoma. In: Advances in Radiopharmacology. Maddalena, D.J., ed., 114–127 (1990).

    Google Scholar 

  13. Tamat, S.R.; Patwardhan, A.; Moore, D.E.; Kabral, A.; Bradstock, K.; Hersey, P.; Allen, B.J. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia. Strahlenther. Onkol. 165, 145–147 (1989).

    PubMed  CAS  Google Scholar 

  14. Mallesch, J.L.; Chiaraviglio, D.; Allen, B.J.; Moore, D.E. An intrapancreatic and hepatic model for Boron Neutron Capture Therapy. AINSE Radiobiology Conference, Sydney, October, 1991. Abstract.

    Google Scholar 

  15. Hill, J.S.; Kahl, S.B.; Kaye, A.H.; Gonzales, M.F.; Vardaxis, N.; Johnson, C.I.; Stylli, S.S.; Nakamura, Y. Tumour localisation of boronated porphyrin in an intracerebral model of glioma. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 501–506 (1992).

    Chapter  Google Scholar 

  16. Tamat, S.R.; Moore, D.E.; Allen, B.J. Boron assay in biological tissue by inductively coupled plasma atomic emission spectroscopy. Anal. Chem. 59, 2161–2164 (1987).

    Article  PubMed  CAS  Google Scholar 

  17. Moore, D.E.; Dawes, A.L.; Allen, B.J.; Bradstock, K.F. Tracking of boron labelled monoclonal antibodies by energy loss spectroscopy in the electron microscopes. In: Advances in Radiopharmacology. Maddalena, D.J., ed., 114–127 (1990).

    Google Scholar 

  18. Moore, D.E.; Stretch, J.R.; Dawes, A.C.; Cockayne, D.; Allen, B.J.; Constantine, G. Uptake ofboronated monoclonal antibodies by melanoma cells visualised by track etch autoradiography and electron energy loss spectroscopy. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 335–338 (1992).

    Chapter  Google Scholar 

  19. Barkla, D.H.; Allen, B.J.; Brown, J.K.; Mountford, M.H.; Ichihashi, M.; Mishima, Y. Morphological changes in human melanoma cells following irradiation with thermal neutrons. Pigm. Cell Res. 2, 345–348 (1989).

    Article  CAS  Google Scholar 

  20. Barkla, D.H.; Brown, J.K.; Meriaty, H.; Allen, B.J. Ultrastructural changes in tumour cells following high or low LET radiation. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 395–398 (1992).

    Chapter  Google Scholar 

  21. Elliston, P.; Pope, J.; Allen, B.J. In vivo determination of boron concentrations in rat tumours using boron-11 nuclear magnetic resonance spectroscopy. EPSM91, Sydney, July 1991. Abstract.

    Google Scholar 

  22. Narayan, K.; Spiropoulos, A. The radio responsiveness of normal and tumour microvasculature. Australas. Radiol. 34, 312–316 (1990).

    Article  PubMed  CAS  Google Scholar 

  23. Allen, B.J.; Brown, J.K; Harrington, B.; Izard, B.; Linklater, H.; Maddalena, D.J.; McNeill, J.; McGregor, B.J.; Mountford, M.H.; Snowdon, G.M.; Wilson, D.J.; Wilson, J.G.; Parsons, P.; Moore, D.; Tamat, S.; Hersey, P. Neutron capture therapy research for malignant melanoma. In: Neutron Capture Therapy. Hatanaka, H., ed., Nishimura, Niigata, 258–280 (1986).

    Google Scholar 

  24. Crotty, K.; Mallesch, J.; Moore, D.E.; Allen, B.J. Histological examination of melanoma xenografts in the nude mouse model; pre and post neutron capture therapy. AINSE Radiobiology Conference, Sydney, October 1991. Abstract.

    Google Scholar 

  25. Martin, R.J.; D'Cunha, G.; Pardee, M.; Allen, B.J. Induction of double strand breaks following neutron capture therapy in DNA bound 157Gd. Int. J. Radiat. Biol. 54, 205–208 (1988).

    Article  PubMed  CAS  Google Scholar 

  26. Martin, R.F.; D'Cunha, G.; Pardee, M.; Allen, B.J. Introduction of DNA double strand breaks by 157Gd neutron capture. Pigm. Cell Res. 2, 330–332 (1989).

    Article  CAS  Google Scholar 

  27. Allen, B.J.; McGregor, B.J.; Martin, R.F. Neutron capture therapy with gadolinium-157. Strahlenther. Onkol. 165, 156–157 (1989).

    PubMed  CAS  Google Scholar 

  28. McGregor, B.J.; Allen, B.J. Filtered beam dose distributions for boron neutron capture therapy of brain tumours. Aust. Phys. Eng. Sci. Med. 7, 27–34 (1984).

    CAS  Google Scholar 

  29. Harrington, B.V. Optimisation of an epithermal beam in HIF AR for boron neutron capture therapy. Ansto/E662 (1987).

    Google Scholar 

  30. Harrington, B.V. A calculational study of tangential and radial beams in HIFAR. In: Neutron Beam, Design, Development and Performance for Neutron Capture Therapy. Harling, O.K.; Bernard, J.A.; Zamenhof, R.G., eds., Plenum Press, New York, 97–106 (1990).

    Chapter  Google Scholar 

  31. Storr, G.J.; Allen, B.J.; Harrington, B.V.; Davis, L.R; Elcombe, M.M.; Meriaty, H. Design considerations for the proposed HIF AR thermal and epithermal NCT facility. In: Progress in Neutron Capture Therapy for Cancer. Allen, B.J.; Moore, D.E.; Harrington, B.V., eds., Plenum Press, New York, 79–82 (1992).

    Chapter  Google Scholar 

  32. Storr, G. Ideal neutron beam assessment for NCT, submitted.

    Google Scholar 

  33. Allen, B.J. Third generation neutron capture therapy for glioblastoma and melanoma brain metastases. Cancer Forum 14, 35–36 (1990).

    Google Scholar 

  34. Allen, B.J. Epithermal neutron capture therapy: a new modality for the treatment of glioblastoma and melanoma metastatic to the brain. Med. J. Aust. 153, 296–298 (1990).

    PubMed  CAS  Google Scholar 

  35. Allen, B.J. Potential of neutron capture therapy for the treatment of localised terminal cancer. Australas. Radiol. 34, 297–305 (1990).

    Article  PubMed  CAS  Google Scholar 

  36. Blagojevic, N.; Allen, B.J.; Storr, G.; Hatanaka, H.; Nakagawa, H. The role of heavy water in dose-depth enhancement in Thermal Neutron Capture Therapy. AINSE Radiobiology Conference, Sydney, October 1991. Abstract.

    Google Scholar 

  37. Allen, B.J.; Coates, A.S.; McCarthy, W.H.; Mameghan, H.; Mishima, Y.; Ichihashi, M. Thermal neutron capture therapy: The JapanaseAustralian clinical trial for malignant melanoma. In: Clinical Aspects of Neutron Capture Therapy, Brookhaven National Laboratory. Fairchild, R.G.; Bond, V.P.; Woodhead, A.D., eds., Plenum Press, New York, 69–73 (1989).

    Chapter  Google Scholar 

  38. Constantine, G. Epithermal Neutron Capture Therapy Facility for HIFAR, February 1991; unpublished report.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Allen, B.J. (1992). The Implementation Strategy for BNCT Trials in Australia. In: Gabel, D., Moss, R. (eds) Boron Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3408-2_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3408-2_26

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6506-8

  • Online ISBN: 978-1-4615-3408-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics